SEC 13F Intelligence

Enavate Sciences GP, LLC / UPB

Enavate Sciences GP, LLC’s Upstream Bio Inc Position

Does Enavate Sciences GP, LLC own Upstream Bio Inc (UPB)? Yes — 2.46M shares worth $22M (+6.30% of its 13F portfolio) as of Q1 2026.

Position Value
$22M
Q1 2026
Shares
2.46M
% of Portfolio
+6.30%
Quarters Held
6
currently held

Position History UPB

Reported value by quarter
Q4 ’24: $40MQ4 ’24Q1 ’25: $15MQ1 ’25Q2 ’25: $27MQ2 ’25Q3 ’25: $46MQ3 ’25Q4 ’25: $67MQ4 ’25Q1 ’26: $22MQ1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 20262.46M$22M+6.30%
Q4 20252.46M$67M+13.18%
Q3 20252.46M$46M+14.13%
Q2 20252.46M$27M+15.30%
Q1 20252.46M$15M+11.34%
Q4 20242.46M$40M+29.04%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Enavate Sciences GP, LLC’s full portfolio or all institutional holders of UPB.